1 1 Page 1 of 16
23...16
Clinical Dialogues are video-based moderated discussions featuring leading experts providing the latest patient management guidelines. eCase Challenges are interactive text or or video-based cases where PAs are presented with challenging case scenarios a
Member: $0.00
Non-Member: $0.00
18.50 AAPA Category 1 CME credit
JAAPA CME post-tests are available in AAPA's monthly clinical journal or online.
Member: $0.00
Non-Member: $25.00
1.00 AAPA Category 1 CME credit
An Update on Expanding HIV Preexposure Prophylaxis | Wellens Syndrome: An Important Consideration in Patients With Chest Pain
Member: $0.00
Non-Member: $25.00
1.00 AAPA Category 1 CME credit
To treat heart failure (HF) effectively, symptoms must first be recognized and followed with an appropriate, timely diagnosis. As well, guideline-directed management must be implemented. The implementation of these recommendations is crucial for maximizing the benefits of HF therapy in clinical practice. Similarly, type 2 diabetes is frequently comorbid with HF, so both conditions require effective co-management. SGLT-2 inhibitors are now indicated for patients with and without diabetes to treat HF, and PAs need to be aware of these new indications. These areas were identified as foundational areas that require additional education. This program is specifically designed to address these gaps and to promote care that will lead to better patient outcomes among patients with HF. Through the tactical combination of online and print formats, this program will appeal to various learning styles and allow participants to reinforce their knowledge and acquire new skills that can immediately be applied to clinical practice.
Member: $0.00
Non-Member: $0.00
0.75 AAPA Category 1 CME credit
To treat heart failure (HF) effectively, symptoms must first be recognized and followed with an appropriate, timely diagnosis. As well, guideline-directed management must be implemented. The implementation of these recommendations is crucial for maximizing the benefits of HF therapy in clinical practice. Similarly, type 2 diabetes is frequently comorbid with HF, so both conditions require effective co-management. SGLT-2 inhibitors are now indicated for patients with and without diabetes to treat HF, and PAs need to be aware of these new indications. These areas were identified as foundational areas that require additional education. This program is specifically designed to address these gaps and to promote care that will lead to better patient outcomes among patients with HF. Through the tactical combination of online and print formats, this program will appeal to various learning styles and allow participants to reinforce their knowledge and acquire new skills that can immediately be applied to clinical practice.
Member: $0.00
Non-Member: $0.00
0.75 AAPA Category 1 Self-Assessment CME credit
To treat heart failure (HF) effectively, symptoms must first be recognized and followed with an appropriate, timely diagnosis. As well, guideline-directed management must be implemented. The implementation of these recommendations is crucial for maximizing the benefits of HF therapy in clinical practice. Similarly, type 2 diabetes is frequently comorbid with HF, so both conditions require effective co-management. SGLT-2 inhibitors are now indicated for patients with and without diabetes to treat HF, and PAs need to be aware of these new indications. These areas were identified as foundational areas that require additional education. This program is specifically designed to address these gaps and to promote care that will lead to better patient outcomes among patients with HF. Through the tactical combination of online and print formats, this program will appeal to various learning styles and allow participants to reinforce their knowledge and acquire new skills that can immediately be applied to clinical practice.
Member: $0.00
Non-Member: $0.00
1.50 AAPA Category 1 CME credit
This podcast series explores the challenges in colorectal screening and how to improve screening rates by reviewing data on causes, incidence rates, and risk factors. This series will cover recommendations and guidance for screening, compare and contrast available screening options, patient communication and more.
Member: $0.00
Non-Member: $0.00
1.50 AAPA Category 1 CME credit
This is the first episode of a three-part podcast series focused on reviewing data on causes, incidence rates, and risk factors associated with colorectal cancer and reflecting on how this pertains to their clinical practices. This podcast will also describe the latest recommendations and guidance for screening and its role in preventing progressive disease, and review the various guidelines on CRCS.
Member: $0.00
Non-Member: $0.00
0.50 AAPA Category 1 CME credit
This is the second episode of a three-part podcast series focused on screening modalities. This episode will compare and contrast available screening options details such as benefits, risks, costs, and outcomes.
Member: $0.00
Non-Member: $0.00
0.50 AAPA Category 1 CME credit
This is the final episode of a three-part podcast series focused on patient communication. This episode covers how to work collaboratively with patients using shared decision-making information focused on CRC screening. We will also assess barriers to adherence to CRC screening and implement strategies to improve adherence.
Member: $0.00
Non-Member: $0.00
0.50 AAPA Category 1 CME credit
1 1 Page 1 of 16
23...16